NDC Code(s) : 68462-298-17, 68462-298-55
Packager : Glenmark Pharmaceuticals Inc. USA
Category : HUMAN PRESCRIPTION DRUG LABEL
DEA Schedule : none
Marketing Status : New Drug Application
INGREDIENTS AND APPEARANCE
Clotrimazole and Betamethasone DipropionateClotrimazole and Betamethasone Dipropionate CREAM | ||||||||||||||||||||||||
|
||||||||||||||||||||||||
|
||||||||||||||||||||||||
|
||||||||||||||||||||||||
|
||||||||||||||||||||||||
|
LABELER - Glenmark Pharmaceuticals Inc. USA(130597813) |
Establishment | |||
Name | Address | ID/FEI | Business Operations |
Glenmark Pharmaceuticals Limited | 676115028 | ANALYSIS(68462-298), MANUFACTURE(68462-298) |
PRINCIPAL DISPLAY PANEL
NDC 68462-298-55
Clotrimazole and Betamethasone Dipropionate Cream USP, 1%/0.05% (base)
FOR TOPICAL USE ONLY. NOT FOR OPHTHALMIC, ORAL, OR INTRAVAGINAL USE. NOT RECOMMENDED FOR PATIENTS UNDER THE AGE OF 17 YEARS AND NOT RECOMMENDED FOR DIAPER DERMATITIS.

PRINCIPAL DISPLAY PANEL
NDC 68462-298-17
Clotrimazole and Betamethasone Dipropionate Cream USP, 1%/0.05% (base)
FOR TOPICAL USE ONLY. NOT FOR OPHTHALMIC, ORAL, OR INTRAVAGINAL USE. NOT RECOMMENDED FOR PATIENTS UNDER THE AGE OF 17 YEARS AND NOT RECOMMENDED FOR DIAPER DERMATITIS.
